Correlation Between Pfizer and Inventiva
Can any of the company-specific risk be diversified away by investing in both Pfizer and Inventiva at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Inventiva into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Inventiva Sa, you can compare the effects of market volatilities on Pfizer and Inventiva and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Inventiva. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Inventiva.
Diversification Opportunities for Pfizer and Inventiva
Excellent diversification
The 3 months correlation between Pfizer and Inventiva is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Inventiva Sa in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inventiva Sa and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Inventiva. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inventiva Sa has no effect on the direction of Pfizer i.e., Pfizer and Inventiva go up and down completely randomly.
Pair Corralation between Pfizer and Inventiva
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Inventiva. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 2.12 times less risky than Inventiva. The stock trades about -0.19 of its potential returns per unit of risk. The Inventiva Sa is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 267.00 in Inventiva Sa on September 13, 2024 and sell it today you would lose (8.00) from holding Inventiva Sa or give up 3.0% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 97.67% |
Values | Daily Returns |
Pfizer Inc vs. Inventiva Sa
Performance |
Timeline |
Pfizer Inc |
Inventiva Sa |
Pfizer and Inventiva Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pfizer and Inventiva
The main advantage of trading using opposite Pfizer and Inventiva positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Inventiva can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inventiva will offset losses from the drop in Inventiva's long position.Pfizer vs. AbbVie Inc | Pfizer vs. Merck Company | Pfizer vs. Eli Lilly and | Pfizer vs. Bristol Myers Squibb |
Inventiva vs. Puma Biotechnology | Inventiva vs. Iovance Biotherapeutics | Inventiva vs. Sarepta Therapeutics | Inventiva vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |